Global Intravenous Solutions (Colloids) Competitive Landscape Professional Research Report 2024

Research Summary

Intravenous solutions containing colloids are sterile liquid preparations administered directly into the veins for therapeutic purposes. Unlike crystalloid solutions, which primarily consist of electrolytes and water, colloids contain larger particles, often in the form of proteins or synthetic substances, that remain suspended in the solution. These colloidal solutions are used to address conditions where there is a need to increase the oncotic pressure within the blood vessels or to support plasma volume expansion. Albumin and synthetic colloids like hydroxyethyl starch are examples of colloidal solutions frequently used in intravenous therapy. Colloids help to retain fluid within the blood vessels and can be employed in situations such as hypovolemic shock, severe burns, or major surgeries where maintaining adequate intravascular volume is crucial. The use of intravenous colloids requires careful consideration of the patient's medical condition, and their administration is typically under medical supervision to ensure appropriate dosage and monitoring for potential side effects.

According to DIResearch's in-depth investigation and research, the global Intravenous Solutions (Colloids) market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Intravenous Solutions (Colloids) include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, Amanta Healthcare, Grifols S.A., Terumo Medical Corporation etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Intravenous Solutions (Colloids). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravenous Solutions (Colloids) market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Intravenous Solutions (Colloids) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravenous Solutions (Colloids) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Intravenous Solutions (Colloids) Include:

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Grifols S.A.

Terumo Medical Corporation

Intravenous Solutions (Colloids) Product Segment Include:

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Intravenous Solutions (Colloids) Product Application Include:

Hospital and Clinics

Ambulatory

Home Care

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Intravenous Solutions (Colloids) Industry PESTEL Analysis

Chapter 3: Global Intravenous Solutions (Colloids) Industry Porter's Five Forces Analysis

Chapter 4: Global Intravenous Solutions (Colloids) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Intravenous Solutions (Colloids) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Intravenous Solutions (Colloids) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Intravenous Solutions (Colloids) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Intravenous Solutions (Colloids) Market Overview

1.1 Product Definition and Statistical Scope

1.2 Intravenous Solutions (Colloids) Product by Type

1.2.1 Global Intravenous Solutions (Colloids) Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Peripheral Parenteral Nutrition

1.2.3 Total Parenteral Nutrition

1.3 Intravenous Solutions (Colloids) Product by Application

1.3.1 Global Intravenous Solutions (Colloids) Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital and Clinics

1.3.3 Ambulatory

1.3.4 Home Care

1.4 Global Intravenous Solutions (Colloids) Market Revenue and Sales Analysis

1.4.1 Global Intravenous Solutions (Colloids) Market Size Analysis (2019-2030)

1.4.2 Global Intravenous Solutions (Colloids) Market Sales Analysis (2019-2030)

1.4.3 Global Intravenous Solutions (Colloids) Market Sales Price Trend Analysis (2019-2030)

1.5 Intravenous Solutions (Colloids) Market Development Status and Trends

1.5.1 Intravenous Solutions (Colloids) Industry Development Status Analysis

1.5.2 Intravenous Solutions (Colloids) Industry Development Trends Analysis

2 Intravenous Solutions (Colloids) Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Intravenous Solutions (Colloids) Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Intravenous Solutions (Colloids) Market Analysis by Regions

4.1 Intravenous Solutions (Colloids) Overall Market: 2023 VS 2024 VS 2030

4.2 Global Intravenous Solutions (Colloids) Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Intravenous Solutions (Colloids) Revenue and Market Share by Region (2019-2024)

4.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Region (2025-2030)

4.3 Global Intravenous Solutions (Colloids) Sales and Forecast Analysis (2019-2030)

4.3.1 Global Intravenous Solutions (Colloids) Sales and Market Share by Region (2019-2024)

4.3.2 Global Intravenous Solutions (Colloids) Sales Forecast by Region (2025-2030)

4.4 Global Intravenous Solutions (Colloids) Sales Price Trend Analysis (2019-2030)

5 Global Intravenous Solutions (Colloids) Market Size by Type and Application

5.1 Global Intravenous Solutions (Colloids) Market Size by Type

5.1.1 Global Intravenous Solutions (Colloids) Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Intravenous Solutions (Colloids) Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Intravenous Solutions (Colloids) Market Size by Application

5.2.1 Global Intravenous Solutions (Colloids) Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Intravenous Solutions (Colloids) Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Intravenous Solutions (Colloids) Market Size by Type

6.3.1 North America Intravenous Solutions (Colloids) Sales by Type (2019-2030)

6.3.2 North America Intravenous Solutions (Colloids) Revenue by Type (2019-2030)

6.4 North America Intravenous Solutions (Colloids) Market Size by Application

6.4.1 North America Intravenous Solutions (Colloids) Sales by Application (2019-2030)

6.4.2 North America Intravenous Solutions (Colloids) Revenue by Application (2019-2030)

6.5 North America Intravenous Solutions (Colloids) Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Intravenous Solutions (Colloids) Market Size by Type

7.3.1 Europe Intravenous Solutions (Colloids) Sales by Type (2019-2030)

7.3.2 Europe Intravenous Solutions (Colloids) Revenue by Type (2019-2030)

7.4 Europe Intravenous Solutions (Colloids) Market Size by Application

7.4.1 Europe Intravenous Solutions (Colloids) Sales by Application (2019-2030)

7.4.2 ? Europe Intravenous Solutions (Colloids) Revenue by Application (2019-2030)

7.5 Europe Intravenous Solutions (Colloids) Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Intravenous Solutions (Colloids) Market Size by Type

8.3.1 China Intravenous Solutions (Colloids) Sales by Type (2019-2030)

8.3.2 China Intravenous Solutions (Colloids) Revenue by Type (2019-2030)

8.4 China Intravenous Solutions (Colloids) Market Size by Application

8.4.1 China Intravenous Solutions (Colloids) Sales by Application (2019-2030)

8.4.2 China Intravenous Solutions (Colloids) Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Intravenous Solutions (Colloids) Market Size by Type

9.3.1 APAC (excl. China) Intravenous Solutions (Colloids) Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Intravenous Solutions (Colloids) Revenue by Type (2019-2030)

9.4 APAC (excl. China) Intravenous Solutions (Colloids) Market Size by Application

9.4.1 APAC (excl. China) Intravenous Solutions (Colloids) Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Intravenous Solutions (Colloids) Revenue by Application (2019-2030)

9.5 APAC (excl. China) Intravenous Solutions (Colloids) Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Intravenous Solutions (Colloids) Market Size by Type

10.3.1 Latin America Intravenous Solutions (Colloids) Sales by Type (2019-2030)

10.3.2 Latin America Intravenous Solutions (Colloids) Revenue by Type (2019-2030)

10.4 Latin America Intravenous Solutions (Colloids) Market Size by Application

10.4.1 Latin America Intravenous Solutions (Colloids) Sales by Application (2019-2030)

10.4.2 Latin America Intravenous Solutions (Colloids) Revenue by Application (2019-2030)

10.5 Latin America Intravenous Solutions (Colloids) Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Intravenous Solutions (Colloids) Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Type

11.3.1 Middle East & Africa Intravenous Solutions (Colloids) Sales by Type (2019-2030)

11.3.2 Middle East & Africa Intravenous Solutions (Colloids) Revenue by Type (2019-2030)

11.4 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Application

11.4.1 Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2019-2030)

11.4.2 Middle East & Africa Intravenous Solutions (Colloids) Revenue by Application (2019-2030)

11.5 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Intravenous Solutions (Colloids) Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Intravenous Solutions (Colloids) Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Intravenous Solutions (Colloids) Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Intravenous Solutions (Colloids) Average Sales Price by Manufacturers (2020-2024)

12.2 Intravenous Solutions (Colloids) Competitive Landscape Analysis and Market Dynamic

12.2.1 Intravenous Solutions (Colloids) Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 ICU Medical Inc.

13.1.1 ICU Medical Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio

13.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 B. Braun Melsungen AG

13.2.1 B. Braun Melsungen AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio

13.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Fresenius Kabi AG

13.3.1 Fresenius Kabi AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio

13.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Baxter

13.4.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Baxter Intravenous Solutions (Colloids) Product Portfolio

13.4.3 Baxter Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Amanta Healthcare

13.5.1 Amanta Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio

13.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Grifols S.A.

13.6.1 Grifols S.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio

13.6.3 Grifols S.A. Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Terumo Medical Corporation

13.7.1 Terumo Medical Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio

13.7.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Intravenous Solutions (Colloids) Industry Chain Analysis

14.2 Intravenous Solutions (Colloids) Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Intravenous Solutions (Colloids) Typical Downstream Customers

14.4 Intravenous Solutions (Colloids) Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support